Aspergillus fumigatus is a fungal species that can cause serious illnesses in immunocompromised individuals. Infections caused by A. fumigatus are difficult to eliminate because the fungus often aggregates into small communities called “biofilms,” which protect the pathogens from antifungal agents and help the fungus evade the immune system. GlycoNet scientists Drs. Lynne Howell and Don Sheppard recently identified a key enzyme in A. fumigatus that could lead to therapeutics to treat these fungal infections.
- New technology allows scientists first glimpse of intricate details of Little Foot’s life
- Tissue, scaffold technologies provide new options for breast cancer, other diseases
- High fat diets may over-activate destructive heart disease protein
- A materials science approach to combating coronavirus
- New study proposes a low cost, high efficiency mask design